Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.
Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.
Filter by Form Type:
Industry:Biotechnologyâ
2026-03-16ADPT144BOBULSKY SUSAN plan to sell securities of Adaptive Biotechnologies Corp under Form 144MEDIUM
BOBULSKY SUSAN filed Form 144 to notify SEC of plan to sell 41338 units of Adaptive Biotechnologies Corp securities around 2026-03-11, with aggregate market value of $600,227.76. The total outstanding units is 153981561.0. The amount planned to be sold represents 0.03% of total outstanding units; ...
Mid CapBiotechnology
2026-03-16ALLO144Beneski Benjamin Machinas plan to sell securities of Allogene Therapeutics, Inc. under Form 144MEDIUM
Beneski Benjamin Machinas filed Form 144 to notify SEC of plan to sell 4835 units of Allogene Therapeutics, Inc. securities around 2026-03-16, with aggregate market value of $11,927.50. The total outstanding units is 243777920.0. The amount planned to be sold represents 0.00% of total outstanding units; ...
Small CapBiotechnology
2026-03-16BCAX144Cohlhepp Ryan plan to sell securities of Bicara Therapeutics Inc. under Form 144MEDIUM
Cohlhepp Ryan filed Form 144 to notify SEC of plan to sell 12500 units of Bicara Therapeutics Inc. securities around 2026-03-16, with aggregate market value of $241,750.00. The total outstanding units is 54781950.0. The amount planned to be sold represents 0.02% of total outstanding units; Recent transactions in past 3...
Small CapBiotechnology